22-43889346-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000216177.9(PNPLA5):c.685A>G(p.Ile229Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000216177.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PNPLA5 | NM_138814.4 | c.685A>G | p.Ile229Val | missense_variant | 4/9 | ENST00000216177.9 | NP_620169.1 | |
PNPLA5 | NM_001177675.2 | c.343A>G | p.Ile115Val | missense_variant | 2/7 | NP_001171146.1 | ||
PNPLA5 | NM_001371410.1 | c.265A>G | p.Ile89Val | missense_variant | 4/9 | NP_001358339.1 | ||
PNPLA5 | XM_047441164.1 | c.265A>G | p.Ile89Val | missense_variant | 2/7 | XP_047297120.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PNPLA5 | ENST00000216177.9 | c.685A>G | p.Ile229Val | missense_variant | 4/9 | 1 | NM_138814.4 | ENSP00000216177 | P1 | |
PNPLA5 | ENST00000381198.7 | c.343A>G | p.Ile115Val | missense_variant | 2/7 | 2 | ENSP00000370595 | |||
PNPLA5 | ENST00000438734.1 | c.427-1695A>G | intron_variant | 3 | ENSP00000405732 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.685A>G (p.I229V) alteration is located in exon 4 (coding exon 4) of the PNPLA5 gene. This alteration results from a A to G substitution at nucleotide position 685, causing the isoleucine (I) at amino acid position 229 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.